Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
2.61
0.00 (0.00%)
USD |
OTCM |
Feb 19, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 6.970B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 41.15% |
| Valuation | |
| PE Ratio | 15.18 |
| PE Ratio (Forward) | |
| PS Ratio | 1.261 |
| Price to Book Value | 1.033 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 0.0446 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.77 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 83.84% |
Profile
| Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China. |
| URL | http://www.fosunpharma.com |
| Investor Relations URL | https://www.fosunpharma.com/en/investor/investor-index.html |
| HQ State/Province | Shanghai |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 24, 2026 (est.) |
| Last Earnings Release | Aug. 26, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jul. 28, 2025 |
Profile
| Shanghai Fosun Pharmaceutical Group Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products and medical equipment, import and export of medical equipment, healthcare services, and the provision of related and other consulting services and investment management. It operates through the following business segment: Pharmaceutical Manufacturing and R&D; Healthcare Service; Medical Devices and Medical Diagnosis; Pharmaceutical Distribution and Retail; and Other Business Operations. The Pharmaceutical Manufacturing and R&D segment involves in the production, sale, and research of medicine. The Healthcare Service segment provides healthcare service and hospital management. The Medical Devices and Medical Diagnosis segment focuses on the production and sale of medical equipment and diagnostic products. The Pharmaceutical Distribution and Retail segment issue retail and wholesale of medicine. The Other Business Operations segment comprises business that is different from the role of other segments. The company was founded on January 14, 1994 and is headquartered in Shanghai, China. |
| URL | http://www.fosunpharma.com |
| Investor Relations URL | https://www.fosunpharma.com/en/investor/investor-index.html |
| HQ State/Province | Shanghai |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Mar. 24, 2026 (est.) |
| Last Earnings Release | Aug. 26, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jul. 28, 2025 |